Abstract
The membrane permeability of drug molecules imparts a significant role in the development of new therapeutic agents. Accordingly, methods to predict the passive permeability of drug candidates during a medicinal chemistry campaign offer the potential to accelerate the drug design process. In this work, we combine the physics-based Site identification by ligand competitive saturation (SILCS) method with data-driven artificial intelligence (AI) to create a high-throughput predictive model for passive permeability of drug-like molecules. In the study we present a comparative analysis of four regression models to predict membrane permeabilities of small drug-like molecules. The input feature vector used to train the developed prediction model includes absolute free energies profiles of ligands through a POPC-cholesterol bilayer based on ligand grid free energy (LGFE) profiles obtained from the SILCS approach. Use of the membrane free energy profiles from SILCS offers information on the physical forces contributing to ligand permeability while the use of AI yields a more predictive model trained on experimental PAMPA permeability data for a collection of 229 molecules. This combination allows for rapid estimations of ligand permeability at a level of accuracy beyond currently available predictive models while offering insights into the contributions of the functional groups in the ligands to the permeability barrier, thereby offering quantitative information to facilitate rational ligand design.
Supplementary materials
Title
Supporting Information
Description
Tables and figures supporting the results presented in the main text. All tables and figures are referred to in the main text.
Actions